Cart
sales@molnova.com
Eculizumab
CAS No. 219685-50-4
Eculizumab( —— )
Catalog No. M22146 CAS No. 219685-50-4
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 954 | In Stock |
|
| 10MG | 1287 | In Stock |
|
| 25MG | 1908 | In Stock |
|
| 50MG | 2574 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEculizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionEculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
-
DescriptionEculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number219685-50-4
-
Formula Weight148 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sheridan D, et al. Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. PLoS One. 2018 Apr 12;13(4):e0195909.
molnova catalog
related products
-
HTHQ
HTHQ, a hydroquinone monoalkyl ether, is an effective anti-oxidative agent.
-
Cystamine dihydrochl...
Cystamine dihydrochloride is a radiation-protective agent. It also protects against carbon tetrachloride liver damage.
-
WR-99210
WR-99210 is a potent inhibitor of?Plasmodium falciparum?dihydrofolate reductase (pfDHFR), which is a major malarial drug target.
